Brind.

HSBC upgraded Gilead Sciences stock, citing pessimistic consensus.

1 report, 1 independent Updated Jul 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

HSBC Gilead Sciences

Keep exploring

The entities involved

HSBC
British multinational bank
- Bangladesh Bank is supervising several foreign banks, including State Bank of India, National Bank of Pakistan, and HSBC.Sun 21:51
- Bangladesh Bank is relaxing lending rules for City Group, which owes loans to foreign banks like HSBC.Sun 21:51
Gilead Sciences
American company
- Amgen and Gilead Sciences are two companies that compete within the biotech industry.Sun 11:22
- Gilead Sciences is commercializing medicines in Europe, with Anu Osinusi as VP of Clinical Development and Cynthia Levy supporting IDEAL results for Livdelzi.Fri 16:08

Related events

Benzinga generated content regarding the financial performance of Gilead Sciences on June 17, 2026.Jun 18
Gabriela Borges upgraded CoreWeave stock to Buy, while HSBC tore apart Goldman Sachs's bullish case.Thu 18:29
HSBC upgraded its stock rating, and Nomura reiterated its Buy rating while raising the target price for Mahindra & Mahindra Financial Services.Jul 22

Coverage

Newest first; wire copies grouped

Jul 6benzinga.com